SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by FineMark National Bank & Trust

FineMark National Bank & Trust trimmed its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,911 shares of the exchange traded fund’s stock after selling 200 shares during the quarter. FineMark National Bank & Trust’s holdings in SPDR S&P Biotech ETF were worth $442,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the company. Addison Advisors LLC boosted its holdings in SPDR S&P Biotech ETF by 27.4% in the fourth quarter. Addison Advisors LLC now owns 535 shares of the exchange traded fund’s stock valued at $48,000 after purchasing an additional 115 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of SPDR S&P Biotech ETF by 0.6% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 23,873 shares of the exchange traded fund’s stock worth $2,373,000 after buying an additional 148 shares during the last quarter. Invst LLC boosted its holdings in shares of SPDR S&P Biotech ETF by 6.0% in the 3rd quarter. Invst LLC now owns 2,807 shares of the exchange traded fund’s stock valued at $277,000 after buying an additional 160 shares in the last quarter. Beech Hill Advisors Inc. grew its position in shares of SPDR S&P Biotech ETF by 2.5% in the 4th quarter. Beech Hill Advisors Inc. now owns 6,655 shares of the exchange traded fund’s stock valued at $599,000 after buying an additional 162 shares during the last quarter. Finally, Wealth Alliance raised its stake in SPDR S&P Biotech ETF by 4.4% during the 4th quarter. Wealth Alliance now owns 4,083 shares of the exchange traded fund’s stock worth $368,000 after acquiring an additional 173 shares in the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of XBI opened at $85.08 on Thursday. SPDR S&P Biotech ETF has a 1-year low of $81.14 and a 1-year high of $105.47. The stock has a market cap of $5.52 billion, a PE ratio of 11.47 and a beta of 0.99. The firm has a fifty day moving average price of $89.52 and a 200 day moving average price of $94.12.

SPDR S&P Biotech ETF Cuts Dividend

The company also recently announced a dividend, which was paid on Wednesday, March 26th. Stockholders of record on Monday, March 24th were issued a $0.0053 dividend. The ex-dividend date of this dividend was Monday, March 24th.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.